Figure 2. Efficacy of novel NKCC1 inhibitors on post-stroke survival and neurological function in mice after t-MCAO.
(A) Changes of body weight and survival. (B) Neurological score, corner test, foot-fault test. (C) Adhesive removal and contact tests. Data are mean ± SD, n = 5-9 (male, n = 3-6; female, n = 2-3).